NAXION
Brent Whitesell has a diverse work experience spanning multiple roles and positions. Brent began their career at Global Sports Publications in September 2011 as an Ad Sales Director. In March 2012, they moved on to NAXION and started as an Associate Operations Manager. Over the years, they steadily climbed the corporate ladder, taking on various roles such as Operations Manager, Senior Operations Manager, and eventually Associate Group Operations Director in March 2016. Brent continued to advance within the company, becoming Group Operations Director in March 2018 and then Senior Group Operations Director in March 2020. Currently, Brent holds the position of Executive Director, Operations Management at NAXION, starting in April 2022.
Brent Whitesell obtained their Bachelor of Science (BS) degree in Economics from Penn State University, where they studied from 2005 to 2009.
NAXION
Our Enterprise Mission NAXION is a broadly-resourced, nimble boutique that relies on advanced analytics, data integration, and sector experience to help businesses direct the destinies of their brands. The firm is distinguished by a genuine synthesis of research proficiency and astute business consulting, supported by one of the industry’s most inventive and customizable toolkits. The acuity of our thinking is matched by the exceptional quality of our process. Our Origins & Culture NAXION’s hybrid “enterprise DNA” is rooted in century-old origins as the world’s first business intelligence firm, National Analysts, which played a critical role in the development of the discipline. Subsequent decades as a division of Booz.Allen & Hamilton established a new leadership role for the firm in advancing data-driven decision cultures across a range of industries. Today, NAXION is an independent, employee and woman-owned firm fiercely dedicated to industry leadership and innovation. Our exceptional commitment to client service and partnership is enabled by a unique boutique culture offering global decision support. Our Services & Sectors NAXION engagements routinely address market entry strategy and customer segmentation, opportunity assessment and forecasting, product development, brand value creation and strength, customer experience, pricing strategy, and lifecycle management. Our specialized NAscence Group supports Life Sciences innovation and commercialization with a suite of services scaled to Big Pharma or emerging Biotech, including forecasting, clinical trials design, and market entry strategy. Specialized industry practices include Health & Life Sciences, Financial Services, Information Technology, Consumer Products, Building & Industrial Systems, Vehicles & Heavy Equipment, and Energy. Depth of experience across a range of B2B industries equips us to help client enterprises understand and meet the needs of business customers in complex market ecosystems.